Publications

2014

Austdal M, Skråstad RB, Gundersen AS, Austgulen R, Iversen AC, Bathen TF: Metabolomic Biomarkers in Serum and Urine in Women with Preeclampsia. PLoS One 2014 [Accepted for publication]

Gadiya M, Mori N, Cao MD, Mironchik Y, Kakkad S, Gribbestad IS, Glunde K, Krishnamachary B, Bhujwalla ZM: Phospholipase D1 and choline kinase-α are interactive targets in breast cancer. Cancer Biol Ther 2014 [Epub ahead of print]

Stensjøen AL, Solheim O, Berntsen EM: Butterfly Glioma. Tidsskr Nor Lægeforen 2014; 134(3); 309

Chronaiou I, Stensjøen AL, Sjøbakk TE, Esmaeili M, Bathen TF: Impacts of MR spectroscopic imaging on glioma patient management. Acta Oncol 2014 [Accepted for publication].

Esmaeili M, Moestue SA, Hamans BC, Veltien A, Kristian A, Engebråten O, Mælandsmo GM, Gribbestad IS, Bathen TF, Heerschap A: In vivo 31P MRSI for metabolic profiling of human breast cancer xenografts. J Magn Reson Imaging 2014 [Epub ahead of print].

Grinde MT, Skrbo N, Moestue SA, Rødland EA, Borgan E, Kristian A, Sitter B, Bathen TF, Børresen-Dale AL, Mælandsmo GM, Engebraaten O, Sørlie T, Marangoni E, Gribbestad IS: Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Res 2014; 16(1); R5

Hak S, Cebulla J, Huuse EM, Davies Cde L, Mulder WJ, Larsson HB, Haraldseth O: Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast-enhanced magnetic resonance imaging and intravital microscopy.

2013

Moestue SA, Huuse EM, Lindholm EM, Bofin A, Engebraaten O, Maelandsmo GM, Akslen LA, Gribbestad IS: Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. J Magn Reson Imaging. 2013 Mar 21. doi: 10.1002/jmri.24079. [Epub ahead of print]

Esmaeili M, Bathen TF, Engebråten O, Maelandsmo GM, Gribbestad IS, Moestue SA: Quantitative 31 P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. Magn Reson Med. 2013 Jul 22. doi: 10.1002/mrm.24869. [Epub ahead of print]

Vettukattil R, Hetland TE, Flørenes VA, Kærn J, Davidson B, Bathen TF: 1H MR Metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma. Hum Pathology 2013; doi:pii: S0046-8177(13)00093-2. 10.1016/j.humpath.2013.02.009. [Epub ahead of print]

Giskeødegård GF, Bertilsson H, Selnæs KM, Wright AJ, Bathen TF, Viset T, Halgunset J, Angelsen A, Gribbestad IS, Tessem MB: Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness. PLoS One. 2013 Apr 23;8(4):e62375

Bathen TF, Geurts B, Sitter B, Fjøsne HE, Lundgren S, Buydens LM, Gribbestad IS, Postma G, Giskeødegård GF: Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery. PLoS One. 2013 Apr 17;8(4):e61578

Esmaeili M, Vettukattil R, Bathen TF: 2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping. Transl Oncol. 2013 Apr;6(2):92-8.

Moestue SA, Dam CG, Gorad SS, Kristian A, Bofin A, Mælandsmo GM, Engebråten O, Gribbestad IS, Bjørkøy G: Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Res. 2013 Feb 28;15(1):R16. [Epub ahead of print]

Wright AJ, Kobus T, Selnaes KM, Gribbestad IS, Weiland E, Scheenen TW, Heerschap A. Quality control of prostate (1) H MRSI data. NMR Biomed. 2013; 26(2); 193-203

Sjøbakk TE, Vettukattil R, Gulati M, Gulati S, Lundgren S, Gribbestad IS, Torp SH, Bathen TF: Metabolic profiles of brain metastases. Int J Mol Sci. 2013 Jan 22;14(1):2104-18.

Selnaes KM, Gribbestad IS, Bertilsson H, Wright A, Angelsen A, Heerschap A, Tessem MB. Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score. NMR Biomed. 2013 May;26(5):600-6

Vettukattil R, Gulati M, Sjøbakk TE, Jakola AS, Kvernmo NAM, Torp SH, Bathen, TF,Gulati, S,Gribbestad, IS. Differentiating Diffuse WHO Grade II and IV Astrocytomas Using Ex Vivo MR Spectroscopy. Neurosurgery 2013; 72(2); 186-195.

2012

Kim E, Cebulla J, Douglas Ward B, Rhie K, Zhang J, Pathak AP. Assessing breast cancer angiogenesis in vivo: Which susceptibility contrast MRI biomarkers are relevant? Magn Reson Med. 2012 Dec 6. doi: 10.1002/mrm.24530. [Epub ahead of print]

Borgan E, Lindholm EM, Moestue S, Mælandsmo GM, Lingjærde OC, Gribbestad IS, Børresen-Dale AL, Engebraaten O, Sørlie T. Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Mol Oncol. 2012 Oct 23. doi:pii: S1574-7891(12)00103-2. 10.1016/j.molonc.2012.10.005. [Epub ahead of print]

Selnæs KM, Heerschap A, Jensen LR, Tessem MB, Jarosch-Von Schweder G, Goa PE, Viset T, Angelsen A and Gribbestad IS. Peripheral Zone Prostate Cancer Localization by Multiparametric MR at 3 T – Unbiased Cancer Identification by Matching to Histopathology. Investigative Radiology 2012; 47; 624-633.

Moestue SA, Giskeodegard GF, Cao MD, Bathen TF, Gribbestad IS. Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer. Proc Natl Acad Sci U S A. 2012; 109 (38); E2506

Bye A, Vettukattil R, Aspenes ST, Giskeødegård GF, Gribbestad IS, Wisloff U, Bathen TF. (2012) Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study. PLoS ONE 2012 7(7): e42330. doi:10.1371/journal.pone.0042330

Moestue SA, Gribbestad IS, Hansen R (2012) Intravascular targets for molecular contrast-enhanced ultrasound imaging. Int J Mol Sci 2012; 13; 6679-6697.
 
Kim E, Stamatelos S, Cebulla J, Bhujwalla ZM, Popel AS, Pathak AP. Multiscale Imaging and Computational Modeling of Blood Flow in the Tumor Vasculature. Ann Biomed Eng. 2012; 40(11); 2425-2441.
 
Bertilsson H, Tessem MB, Flatberg A, Viset T, Gribbestad I, Angelsen A, Halgunset J. Changes in Gene Transcription Underlying the Aberrant Citrate and Choline Metabolism in Human Prostate Cancer Samples. Clin Cancer Res.2012; 18; 3261-3269
 
Giskeodegard GF, Lundgren S, Sitter B, Fjosne HE, Postma G, Buydens LM, Gribbestad IS, Bathen TF. Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR Biomed. 2012. Epub 2012/03/13. doi: 10.1002/nbm.2798. PubMed PMID: 22407957.

Cao MD, Döpkens M, Krishnamachary B, Vesuna F, Gadiya MM, Lønning PE, Bhujwalla ZM, Gribbestad IS, Glunde K. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer. NMR Biomed. 2012 Jan 26. doi: 10.1002/nbm.2766. [Epub ahead of print]

Cao MD, Giskeodegard GF, Bathen TF, Sitter B, Bofin A, Lonning PE, Lundgren S, Gribbestad IS. Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer. 2012 Jan 25;12(1):39. [Epub ahead of print]

Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Krüger K, Bofin A, Mælandsmo GM, Akslen LA, Engebraaten O, Gribbestad IS. In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts J Magn Reson Imaging 2012; 35; 1098-1107 

2011

Huuse EM, Moestue SA, Lindholm EM, Bathen TF, Nalwoga H, Krüger K, Bofin A, Mælandsmo GM, Akslen LA, Engebraaten O, Gribbestad IS. In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts J Magn Reson Imaging 2011 in press

Bertilsson, H, A. Angelsen, Viset T, Skogseth H, Tessem MB, Halgunset J. "A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy." Prostate 71(5): 461-9.

Jensen LR, Garzon B, Heldahl MG, Bathen TF, Lundgren S, et al. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients. J Magn Reson Imaging 34: 1099-1109.

Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL. Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue Mol Oncol (in press)

Bathen TF, Heldahl MG, Sitter B, Vettukattil R, Bofin A, Lundgren S, Gribbestad IS. In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. MAGMA. 2011 Sep 10. [Epub ahead of print]

Cao MD, Sitter B, Bathen TF, Bofin A, Lønning PE, Lundgren S, Gribbestad IS Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR Biomed, in press 2011

Moestue SA, Engebraaten O, Gribbestad IS. Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy (review), Mol Oncol. 2011 Apr 23. [Epub ahead of print]


Glunde K, Jiang L, Moestue SA, Gribbestad IS: Magnetic Resonance Spectroscopy and Imaging Guidance in Molecular Medicine: Targeting and Monitoring of Choline and Glucose Metabolism in Cancer (review). NMR Biomed, in press 2011

Heldahl M, Lundgren S, Jensen LR, Gribbestad IS, Bathen TF. Monitoring neoadjuvant chemotherapy in breast cancer patients: Improved MR assessment at 3 T?, J Magn Reson Imaging, in press 2011

Grinde MT, Moestue SA, Borgan E, Risa O, Engebraaten O, Gribbestad IS. (13) C High-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns. NMR Biomed. 2011 Apr 4. doi: 10.1002/nbm.1683. [Epub ahead of print]

Moestue S, Sitter B, Bathen TF, Tessem MB, Girbbestad IS.  HR MAS MR spectroscopy in metabolic characterization of cancer. Current Topics in Medicinal Chemistry, 2011;11(1):2-26.

Sitter B, Moestue SA,  Bathen TF. Gribbestad IS. Clinical MR spectroscopy. Helse Medisin Teknikk (Norwegian), nr 2, 2011

2010

Giskeødegård GF, Bloemberg TG, Postma G, Sitter B, Tessem M-B, Gribbestad IS, Bathen TF, Buydens LMC. Alignment of high resolution magic angle spinning magnetic resonance spectra using warping methods. Analytica Chimica Acta;683(1):1-11

Borgan E, Sitter B, Lingjaerde OC, Johnsen H, Lundgren S, Bathen TF, Sorlie T, Borresen-Dale AL, Gribbestad IS. Merging transcriptomics and metabolomics--advances in breast cancer profiling. BMC Cancer;10:628.

Editorial commentary to this article :  Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer? by Howell A.

Tessem MB, Selnaes KM, Sjursen W, Trano G, Giskeodegard GF, Bathen TF, Gribbestad IS, Hofsli E. Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis. J Proteome Res Jul 2;9(7):3664-70.

Bertilsson H, Angelsen A, Viset T, Skogseth H, Tessem MB, Halgunset J. A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy. Prostate Sep 21.

Giskeødegård GF, Grinde MT, Sitter B, Axelson DE, Lundgren S, Fjøsne H, Dahl S, Gribbestad I, Bathen TF. Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. J. Proteome Res., 2010, 9 (2), pp 972–979

Bathen TF, Sitter B, Sjøbakk TE, Tessem MB, Gribbestad IS. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation. Cancer Res. 2010 Sep 1;70(17):6692-6. Epub 2010 Aug 10. PubMed PMID: 20699363.

Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sørlie T, Tagliabue E, Børresen-Dale AL; FEMME Consortium. Triple-negative breast cancer: present challenges and new perspectives. Mol Oncol. 2010 Jun;4(3):209-29. Epub 2010 Apr 24. PubMed PMID: 20537966.

Huuse EM, Jensen LR, Goa PE, Lundgren S, Anderssen E, Bofin A, Gribbestad IS, Bathen TF. Monitoring docetaxel response in MCF7 xenografts using multimodal in vivo and ex vivo magnetic resonance methods, histopathology, and gene expression. Transl Oncol. 2010 Aug 1;3(4):252-63.

Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale AL, Engebraaten O, Maelandsmo GM, Gribbestad IS: Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer 2010;10; 433.

Heldahl MG, Bathen TF, Rydland J, Kvistad KA, Lundgren S, Gribbestad IS, Goa PE. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis. Acta Radiol. 2010 Jul;51(6):604-12.

Sitter B, Bathen TF, Singstad TE, Fjøsne HE, Lundgren S, Halgunset J, Gribbestad IS.   Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.  NMR Biomed. 2010, 23, 424-431.

Wijnen JP, van Asten JJ, Klomp DW, Sjobakk TE, Gribbestad IS, Scheenen TW, Heerschap A. Short echo time 1H MRSI of the human brain at 3T with adiabatic slice-selective refocusing pulses; reproducibility and variance in a dual center setting. J Magn Reson Imaging. 2010 Jan;31(1):61-70.

2009

Jensen LR, Heldahl MG, Goa PE, Lundgren S, Gribbestad IS. Is there a correlation between DCE-MRI and survival? European Radiology 2009, Supplement 4, volume 19, pages s826-s829

Sitter B, Bathen TF, Gribbestad IS. High-resolution MAS MRS of breast cancer biopsies - different approaches.European Radiology 2009: Supplement 4, volume 19, pages s822-s826

Bathen TF, Christensen Løhaugen GC, Brubakk AM, Gribbestad IS, Axelson DE, Skranes J. Combining clinical assessment scores and in vivo MR spectroscopy neurometabolites in very low birth weight adolescents. Artif Intell Med. 2009; 47(2):135-46.

Jensen LR, Huuse EM, Bathen TF, Goa PE, Bofin AM, Pedersen TB, Lundgren S, Gribbestad IS. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo (1)H MRS. NMR Biomed. 2009;23(1):56-65.

Johansen R, Jensen LR, Rydland J, Goa PE, Kvistad KA, Bathen TF, Axelson DE, Lundgren S, Gribbestad IS. Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. J Magn Reson Imaging, 2009,  1300-1307

Sitter B, Bathen TF, Tessem MB, Gribbestad IS. High-resolution magic angel spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer. Progresss in Nuclear Magnetic Resonance Spectroscopy 2009, 54, pages 239-254

Moestue S, Nunez P, Healey A, Bjerke R, Indrevoll B, Skotland T, Hustvedt SO.Whole-body section fluorescence imaging - a novel method for tissue distribution studies of fluorescent substances. Contrast Media & Molecular Imaging 2009 Volume 4, Issue 2, Pages 73-80

2008

Sjøbakk, Torill Eidhammer; Johansen, Roar; Bathen, Tone Frost; Sonnewald, Ursula; Juul, Roar; Torp, Sverre Helge; Lundgren, Steinar; Gribbestad, Ingrid S. Characterization of brain metastases using high-resolution magic angle spinning MRS. NMR in Biomedicine; Volum 21. s. 175-185, 2008

Bathen TF, Holmgren K, Lundemo AG, Hjelstuen MH, Krokan HE, Gribbestad IS, Schønberg SA.. Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice. Anticancer Research 28:3717-3724, 2008

Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. Evaluation of Lactate and Alanine as Metabolic Biomarkers of Prostate Cancer Using ^1 H HR-MAS Spectroscopy of Biopsy Tissues. Magn Reson Med 2008:60(3):510-516.

Gjerde J, Hauglid M, Breilid H, Lundgren S, Varhaug JE, Kisanga ER, Mellgren G, Steen VM, Lien EA. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. Ann Oncol. 2008 Jan;19(1):56-61.

Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case-control study. Lung Cancer. 2008 Aug;61(2):235-43. Epub 2008 Feb 20.

Fjøsne HE, Jacobsen AB, Lundgren S; Norwegian Breast Cancer Group (NBCG). Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up. Eur J Surg Oncol. 2008 Jan;34(1):6-12. Epub 2007 Sep 18.

Johansen R, Westin AA, Bofin AM, Lundgren S. Outcome of whole-brain irradiation for breast cancer patients. Acta Oncol. 2008;47(2):261-6.

Seierstad, T., K. Roe, B. Sitter, J. Halgunset, K. Flatmark, A. H. Ree, D. R. Olsen, I. S. Gribbestad, and T. F. Bathen. 2008. Principal component analysis for comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1H magnetic resonance spectroscopy. /Mol. Cancer/ 7:33.

Sitter B, Bathen TF, Gribbestad IS. /High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy/. I: Cancer Imaging, Volume 2: Elsevier 2008. ISBN 978-0-12-374183-7. s. 45-52

2007

Jensen, LR; Berge, K; Bathen, TF; Wergedahl, H; Schønberg, SA; Bofin, A.; Berge, RK.; Gribbestad, IS. Effect of Dietary Tetradecylthioacetic Acid on Colon Cancer Growth studied by Dynamic Contrast Enhanced MRI. Cancer Biology & Therapy 2007;6(11)

Bathen TF, Jensen LR, Sitter B, Fjosne HE, Halgunset J, Axelson DE, Gribbestad IS, Lundgren S. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res Treat. 2007 Aug;104(2):181-9

Sjøbakk TE, Johansen R, Bathen TF, Sonnewald U, Kvistad KA, Lundgren S, Gribbestad IS. Metabolic profiling of human brain metastases from different primary cancers using in vivo proton MR spectroscopy at 3T. BMC Cancer 2007, 7:141

Stenstrom B, Zhao CM, Rogers AB, Nilsson HO, Sturegard E, Lundgren S, Fox JG, Wang TC, Wadstrom T, Chen D. Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice. Carcinogenesis. 2007

Lyng H, Sitter B, Bathen TF, Jensen LR, Sundfor K, Kristensen GB, Gribbestad IS. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer. 2007 Jan 17;7:11 .

Gribbestad IS, Sjøbakk T, Sitter B, Bathen TF. Clinical MR spectroscopy. Helse Medisin Teknikk (Norwegian), nr 2, 2007

2006

Tessem MB, Bathen TF, Löfgren S, Saether O, Mody V, Meyer L, Dong X, Söderberg PG, Midelfart A. Biological response in various compartments of the rat lens after in vivo exposure to UVR-B analyzed by HR-MAS 1H NMR spectroscopy. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5404-11

Staalesen V, Knappskog S, Chrisanthar R, Nordgard SH, Lokkevik E, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Gram IT, Kristensen VN, Borresen-Dale AL, Lillehaug JR, Lonning PE. The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6000-4. 

Tessem MB, Midelfart A, Cejkova J, Bathen TF. Effect of UVA and UVB irradiation on the metabolic profile of rabbit cornea and lens analysed by HR-MAS 1H NMR spectroscopy. Ophthalmic Res. 2006;38(2):105-14.

Sjøbakk TE, Lundgren S, Kristoffersen A, Singstad T, Svarliaunet Å, Sonnewald U, Gribbestad IS. Clinical 1H MR spectroscopy of brain metastases at 1.5T and 3T. Acta Radiologica. 2006 47(5): 501-508.

Bathen TF, Sjøbakk TE, Skranes J, Brubakk AM, Vik T, Martinussen M, Myhr G, Gribbestad IS, Axelson D. Cerebral metabolite differences in adolescents with low birth weight:assessment with in vivo proton MR spectroscopy. Pediatr Radiol. 2006 Aug;36(8):802-9.

Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 2006 19(1):30-40

Drageset V, Nesland JM, Erikstein B, Skovlund E, Sommer H, Anker G, Wist E, Lundgren S, Bergh J, Kvalheim G. Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy. Int J Cancer. 2006 Jun 1;118(11):2877-81

2005 and older papers (doc)

Siver Andreas Moestue
Wed, 26 Feb 2014 14:18:00 +0100

Contact

Tone Frost Bathen Tone F. Bathen

The MR Cancer Group can be found at the MR Centre at NTNU and St. Olavs Hospital in Trondheim. The group belongs to the Department of Circulation and Medical Imaging (ISB), the Faculty of Medicine, NTNU.

>> See map.